Viewing Study NCT01869634


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-02-25 @ 6:51 PM
Study NCT ID: NCT01869634
Status: COMPLETED
Last Update Posted: 2020-03-04
First Post: 2013-06-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
Sponsor: University of California, Davis
Organization:

Study Overview

Official Title: Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Potent HIV suppression with Darunavir-based antiretroviral therapy (ART) will lead to repopulation of gastrointestinal-associated lymphoid tissue (GALT) cluster of differentiation (CD)4+ T-cell populations, normalization of systemic immune activation, and improved HIV-associated cardiovascular disease (CVD) risk.
Detailed Description: Rationale Infection with HIV causes significant morbidity and mortality, even among individuals who are virologically suppressed with combination anti-retroviral therapy (ART). ART is effective in prolonging life and enabling individuals who are HIV positive to live near-normal life spans. However, these individuals are increasingly developing a number of chronic diseases of aging, such as atherosclerotic cardiovascular disease (ASCVD). The proposed studies will examine the role of highly active antiretroviral therapy in restoring the mucosal immunity and the systemic effect on immune activation, bacterial translocation, and change in HIV-associated cardiovascular disease risk.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
IIS RFA _Asmuth:TMC114HIV2029 OTHER Other View